Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 21,282,686 shares, a decrease of 5.7% from the July 31st total of 22,575,038 shares. Based on an average daily volume of 1,020,475 shares, the days-to-cover ratio is currently 20.9 days. Currently, 25.5% of the shares of the stock are sold short.

In other news, Director William Grieco sold 2,000 shares of the company’s stock in a transaction on Friday, June 16th. The shares were sold at an average price of $45.42, for a total value of $90,840.00. Following the transaction, the director now owns 47,013 shares of the company’s stock, valued at $2,135,330.46. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Christopher L. Howard sold 53,713 shares of the company’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $2,722,711.97. Following the completion of the transaction, the executive vice president now directly owns 147,286 shares in the company, valued at approximately $7,465,927.34. The disclosure for this sale can be found here. In the last ninety days, insiders sold 3,962,387 shares of company stock worth $197,947,257. Insiders own 11.10% of the company’s stock.

A number of hedge funds have recently made changes to their positions in ACHC. Nationwide Fund Advisors boosted its stake in shares of Acadia Healthcare by 683.9% in the first quarter. Nationwide Fund Advisors now owns 75,852 shares of the company’s stock valued at $3,307,000 after buying an additional 66,176 shares during the last quarter. First Mercantile Trust Co. boosted its stake in shares of Acadia Healthcare by 49.3% in the first quarter. First Mercantile Trust Co. now owns 10,175 shares of the company’s stock valued at $443,000 after buying an additional 3,359 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in shares of Acadia Healthcare by 43.9% in the first quarter. Russell Investments Group Ltd. now owns 221,649 shares of the company’s stock valued at $9,664,000 after buying an additional 67,665 shares during the last quarter. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Acadia Healthcare during the first quarter valued at approximately $210,000. Finally, Emerald Advisers Inc. PA boosted its stake in shares of Acadia Healthcare by 2.3% in the first quarter. Emerald Advisers Inc. PA now owns 85,198 shares of the company’s stock valued at $3,715,000 after buying an additional 1,876 shares during the last quarter.

Several research firms have recently weighed in on ACHC. Mizuho upped their price target on shares of Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a report on Friday, July 28th. BidaskClub cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, August 18th. Deutsche Bank AG upped their price target on shares of Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, July 31st. Craig Hallum reaffirmed a “buy” rating and issued a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Finally, UBS AG reaffirmed a “positive” rating and issued a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a report on Monday, July 31st. One analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $59.21.

Acadia Healthcare (NASDAQ ACHC) opened at 46.94 on Friday. The company has a market cap of $4.12 billion, a PE ratio of 515.82 and a beta of 1.15. Acadia Healthcare has a 1-year low of $32.54 and a 1-year high of $54.34. The company has a 50-day moving average price of $49.80 and a 200-day moving average price of $45.57.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.65 by $0.01. The business had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.73 EPS. On average, analysts expect that Acadia Healthcare will post $2.45 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Short Interest in Acadia Healthcare Company, Inc. (ACHC) Drops By 5.7%” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/09/01/short-interest-in-acadia-healthcare-company-inc-achc-drops-by-5-7.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.